Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2010
12/07/2010US7847109 Triptolide derivatives for modulation of apoptosis and immunosuppression
12/07/2010US7847100 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
12/07/2010US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846903 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent
12/07/2010US7846560 Material for organic electroluminescence device and electroluminescence device employing the same
12/07/2010US7846417 controlling the reaction temperature of the exothermic reaction along the length of the reactor to parallel the equilibrium curve for the desired product;
12/07/2010CA2446326C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/02/2010WO2010137662A1 Plant branching inhibitor, method for producing same, and plant branching inhibitory composition
12/02/2010WO2010137285A1 Anthracene derivative and organic electroluminescent element using the same
12/02/2010WO2010137018A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
12/02/2010WO2010136502A1 Process for the production of dronedarone intermediates
12/02/2010WO2010136500A1 Process for the production of benzofurans
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010US20100305337 Use Of The PIGD Protein For Catalyzing 1,4-Additions Of 2-Oxoalkanoates To Alpha, Beta-Unsaturated Ketones
12/02/2010US20100305182 Compounds and methods for modulating communication and virulence in quorum sensing bacteria
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100304296 Salt and photoresist composition containing the same
12/02/2010US20100304294 Salt and photoresist composition containing the same
12/02/2010US20100304292 Salt and photoresist composition containing the same
12/02/2010US20100301313 Benzanthracene compound and organic electroluminescence device using the same
12/02/2010US20100299991 Hydroxymethylfurfural Ethers from Sugars and Olefins
12/02/2010CA2766077A1 Process for the production of dronedarone intermediates
12/02/2010CA2763472A1 Process for the production of benzofurans
12/01/2010EP2254410A1 Methods for inhibiting drug degradation
12/01/2010EP1535916B1 Inclusion complexes of butylphthalide with cyclodextrin derivatives and processes for their preparation
12/01/2010CN101903310A Process for producing organic compound and organic compound obtained by the same
12/01/2010CN101899030A Method for preparing vitamin C calcium salt
12/01/2010CN101899029A Preparation method of vitamin C sodium salt
12/01/2010CN101899028A New furanditerpenoid compound, preparation method and application thereof
12/01/2010CN101899027A Salt and photoresist composition containing the same
12/01/2010CN101899026A Intermediates for the preparation of halichondrin B
12/01/2010CN101898987A Salt and photoresist composition containing the same
12/01/2010CN101898984A Salt and photoresist composition containing the same
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898970A N-monosubstituted trans-1,2-diaminocyclohexane derivatives and preparation method thereof
12/01/2010CN101898103A Molten salt internal circulating reactor with annual output of maleic anhydride up to 20,000t and reaction process thereof
12/01/2010CN101423525B Dialkyl acyloxy[2-(2-methyl allyloxy)phenoxy] aluminum as well as preparation method and application thereof
11/2010
11/30/2010US7842941 can be used as a raw material monomer for a branched polymer compound; light emitting polymers; oligomers, dendrimers and polymer compounds synthesized using these aromatic compounds can also be used as coloring matters for lasers, materials for organic solar batteries, organic semiconductors
11/30/2010US7842832 β-amino-α-cyanoacrylates and their use as herbicides
11/30/2010US7842825 Using 3-(3-chlorobiphenyl-4-oxymethyl)benzoic acid; antidiabetic agents; type 2 diabetes; insulin resistance; impaired glucose tolerance
11/30/2010US7842824 Biphenyltetracarboxylic acid dianhydride and process for producing the same, and polyimide formed from the same and process for producing the same
11/30/2010US7842718 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
11/30/2010US7842164 mixing with cellulose suspension; anionic starch stabilizer
11/30/2010CA2647590C Process for production of ethylenediamine derivatives having halogenated carbamate group and acyl group, and intermediates for production of the derivatives
11/30/2010CA2612827C Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
11/30/2010CA2497868C Heterocyclic compounds
11/30/2010CA2495118C Method for the separation of intermediates which may be used for the preparation of escitalopram
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010134630A1 Production method of halogen-substituted phthalide
11/25/2010WO2010134014A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010US20100298584 Process for production of 4-vinyl-2,3-dihydrobenzofuran
11/25/2010US20100298583 Method for the depolymerization of mixtures that contain mono-and/or diesters of polytetrahydrofurane
11/25/2010US20100298576 Asymmetric cyclization processes using unsaturated nitro compounds
11/25/2010US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
11/25/2010US20100298560 process for preparing mycophenolate mofetil
11/25/2010US20100298559 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298426 Therapeutic agent for substance dependence
11/25/2010US20100298356 Saturated and insaturated bi- or tricyclic aryloxyacetamine derivatives and their use as fungicides
11/25/2010US20100298138 Aminoazoline and Urea Derivatives for Combating Animal Pests
11/25/2010US20100297555 Monomer having electron-withdrawing substituent and lactone skeleton, polymeric compound, and photoresist composition
11/25/2010US20100297542 Sulphonium salt initiators
11/25/2010US20100297261 Food Product and Fortification System Therefor
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/24/2010EP2253636A1 Neuronal cell death inhibitor
11/24/2010EP2253610A1 Method for manufacturing 4-aminobut-2-enolids
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252586A1 Compounds and compositions as modulators of gpr119 activity
11/24/2010EP1694438B1 Catalyst extrudates based on copper oxide and their use for hydrogenating carbonyl compounds
11/24/2010EP1474387B1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes
11/24/2010CN101896476A Conversion of carbohydrates to hydroxy-methylfurfural (HMF) and derivatives
11/24/2010CN101894912A Electric conductivity adjustable organic molecular film and semiconductor hybrid material and preparation method thereof
11/24/2010CN101891722A Method for preparing usnic acid
11/24/2010CN101891721A Method for preparing electronic grade hydrogenated trimellitic anhydride
11/24/2010CN101891720A Dianhydride monomer containing photocrosslinkable phenyl vinyl ketone element and preparation method thereof
11/24/2010CN101891719A Method for synthesizing 2,5-furandicarboxylic acid
11/24/2010CN101891718A Continuous production process for preparing succinyl oxide by maleic anhydride hydrogenation
11/24/2010CN101891717A Preparation method of flavoring difurfuryl sulfide
11/24/2010CN101891716A Synthesis method of S-beta-hydroxy-gamma-butyrolactone
11/24/2010CN101891715A Novel compound and preparation method and use thereof
11/24/2010CN101891714A Method for producing tetrahydrofuran
11/24/2010CN101891689A Preparation method of hydrochloric acid gamma-hydroxy bendamustine
11/24/2010CN101891668A L-prolinamide derivative, preparation method and application of same
11/24/2010CN101891592A Method for preparing 1,4-butanediol and co-producing tetrahydrofuran and gamma-butyrolactone
11/24/2010CN101215275B Vitamin C derivative and preparation method thereof
11/24/2010CN101130532B System and method for producing furol by using agricultural and forestry castoff
11/24/2010CN101130530B System and method for producing furol by using agricultural and forestry castoff
11/23/2010US7838693 Process for the preparation of 3,5-di-O-acyl-2-fluoro-2-C-methyl-D-ribono-gamma-lactone
11/23/2010US7838690 5,6-O-Isopropylidene ascorbic acid reacted with an alkkyl halide in an organic solvent in the presence of an ion exchange resin absorbed with multi-iodine anions and then deprotected; high yield and high purity by reaction at room temperature; kinetics; cost efficiency; industrial scale
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7837981 Methods for imaging soluble A-beta
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2332808C Compositions of ascorbic acid derivatives for treatment of skin diseases
11/18/2010WO2010132740A2 Oxidation of furfural compounds
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 472